Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001652410-25-000003
Filing Date
2025-11-13
Accepted
2025-11-13 18:59:35
Documents
1
Period of Report
2025-11-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1763078372.html 4  
1 FORM 4 wk-form4_1763078372.xml 4 3774
  Complete submission text file 0001652410-25-000003.txt   5201
Mailing Address C/O NEOS THERAPEUTICS, INC. 2940 N. HIGHWAY 360 GRAND PRAIRIE TX 75050
Business Address
Hecht Beth (Reporting) CIK: 0001652410 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40880 | Film No.: 251480358

Mailing Address 1375 WEST FULTON STREET, SUITE 1300 CHICAGO IL 60607
Business Address 1375 WEST FULTON STREET, SUITE 1300 CHICAGO IL 60607 844-445-5704
Xeris Biopharma Holdings, Inc. (Issuer) CIK: 0001867096 (see all company filings)

EIN.: 871082097 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)